Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for 10x Genomics (TXG : NSDQ)

• Company Description    10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. Number of Employees: 410

• Price / Volume Information    Yesterday's Closing Price: $16.31 Daily Weekly Monthly 20 Day Moving Average: 1,749,238 shares Shares Outstanding: 126.55 (millions) Market Capitalization: $2,064.08 (millions) Beta: 2.18 52 Week High: $20.34 52 Week Low: $6.78 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.14% -9.99% 12 Week 39.28% 37.04% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 6230 STONERIDGE MALL ROAD - PLEASANTON,CA 94588 USA ph: 925-401-7300 fax: - investors@10xgenomics.com http://www.10xgenomics.com

• General Corporate Information    Officers Serge Saxonov - Chief Executive Officer and Director John R. Stuelpnagel - Chairman Benjamin J. Hindson - President Adam S. Taich - Chief Financial Officer Sridhar Kosaraju - Director Peer Information 10x Genomics (HLIS) 10x Genomics (AZTA) 10x Genomics (APYI) 10x Genomics (RNVA) 10x Genomics (HMSY) 10x Genomics (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 88025U109 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/11/26 Share - Related Items Shares Outstanding: 126.55 Most Recent Split Date: (:1) Beta: 2.18 Market Capitalization: $2,064.08 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.28 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.87 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 55.94% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.63 Price/Cash Flow: - Price / Sales: 3.22 EPS Growth vs. Year Ago Period: 26.67% vs. Previous Quarter: -178.57% Sales Growth vs. Year Ago Period: -1.75% vs. Previous Quarter: -13.83% ROE 12/31/25 - - 09/30/25 - -11.50 06/30/25 - -12.88 ROA 12/31/25 - - 09/30/25 - -8.93 06/30/25 - -10.03 Current Ratio 12/31/25 - - 09/30/25 - 4.48 06/30/25 - 5.84 Quick Ratio 12/31/25 - - 09/30/25 - 4.06 06/30/25 - 5.23 Operating Margin 12/31/25 - - 09/30/25 - -13.32 06/30/25 - -14.56 Net Margin 12/31/25 - - 09/30/25 - -11.89 06/30/25 - -13.13 Pre-Tax Margin 12/31/25 - - 09/30/25 - -11.39 06/30/25 - -12.31 Book Value 12/31/25 - - 09/30/25 - 6.20 06/30/25 - 6.76 Inventory Turnover 12/31/25 - - 09/30/25 - 2.77 06/30/25 - 2.45 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©